Vimentin: from a cytoskeletal protein to a critical modulator of immune response and a target for infection.


Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2023
Historique:
received: 17 05 2023
accepted: 20 06 2023
medline: 23 10 2023
pubmed: 21 7 2023
entrez: 21 7 2023
Statut: epublish

Résumé

Vimentin is an intermediate filament protein that plays a role in cell processes, including cell migration, cell shape and plasticity, or organelle anchorage. However, studies from over the last quarter-century revealed that vimentin can be expressed at the cell surface and even secreted and that its implications in cell physiology largely exceed structural and cytoskeletal functions. Consequently, vimentin contributes to several pathophysiological conditions such as cancer, autoimmune and inflammatory diseases, or infection. In this review, we aimed at covering these various roles and highlighting vimentin implications in the immune response. We also provide an overview of how some microbes including bacteria and viruses have acquired the ability to circumvent vimentin functions in order to interfere with host responses and promote their uptake, persistence, and egress from host cells. Lastly, we discuss the therapeutic approaches associated with vimentin targeting, leading to several beneficial effects such as preventing infection, limiting inflammatory responses, or the progression of cancerous events.

Identifiants

pubmed: 37475865
doi: 10.3389/fimmu.2023.1224352
pmc: PMC10354447
doi:

Substances chimiques

Vimentin 0
Cytoskeletal Proteins 0
Intermediate Filament Proteins 0

Types de publication

Journal Article Review Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1224352

Informations de copyright

Copyright © 2023 Arrindell and Desnues.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Eur J Biochem. 1989 Aug 1;183(2):441-7
pubmed: 2503376
Methods Enzymol. 2016;568:389-426
pubmed: 26795478
Respir Res. 2020 Aug 27;21(1):224
pubmed: 32854739
J Virol. 2014 Feb;88(4):1897-913
pubmed: 24284321
Blood. 2003 Oct 15;102(8):2901-9
pubmed: 12829607
Oncotarget. 2016 Nov 1;7(44):72021-72032
pubmed: 27713131
Mol Biosyst. 2010 May;6(5):795-806
pubmed: 20567765
BMC Cancer. 2019 Mar 20;19(1):248
pubmed: 30894168
Gut. 2013 May;62(5):695-707
pubmed: 22684479
Nat Rev Microbiol. 2016 Jun;14(6):385-400
pubmed: 27108705
J Biol Chem. 1994 Dec 9;269(49):31097-106
pubmed: 7983050
J Biol Chem. 1998 May 8;273(19):11728-36
pubmed: 9565595
J Cell Biol. 1996 May;133(4):749-60
pubmed: 8666661
J Biol Chem. 2012 Jun 15;287(25):21481-91
pubmed: 22549780
Virus Res. 2015 Mar 16;200:56-63
pubmed: 25533531
Nat Commun. 2019 Sep 13;10(1):4200
pubmed: 31519880
Rheumatology (Oxford). 2011 May;50(5):830-7
pubmed: 21278075
J Clin Invest. 2009 Jun;119(6):1420-8
pubmed: 19487818
Nat Rev Mol Cell Biol. 2004 Aug;5(8):601-13
pubmed: 15366704
J Innate Immun. 2012;4(1):16-30
pubmed: 22067846
Nat Rev Microbiol. 2022 Dec;20(12):750-766
pubmed: 35879556
J Biomed Sci. 2016 Jan 22;23:14
pubmed: 26801988
Biochem Biophys Res Commun. 2006 Dec 22;351(3):625-30
pubmed: 17083913
Cancer Res. 2003 May 15;63(10):2658-64
pubmed: 12750294
Nat Cell Biol. 2003 Jan;5(1):59-63
pubmed: 12483219
Virology. 2016 Oct;497:41-52
pubmed: 27423069
J Immunol. 2006 Jan 1;176(1):652-9
pubmed: 16365461
Cells. 2023 Apr 08;12(8):
pubmed: 37190018
Mol Biol Cell. 2011 Jul 1;22(13):2282-9
pubmed: 21562225
Cell Mol Life Sci. 2011 Sep;68(18):3033-46
pubmed: 21637948
Autoimmun Rev. 2018 Sep;17(9):926-934
pubmed: 30009963
Vet Res. 2023 Jan 30;54(1):7
pubmed: 36717839
Biophys J. 2014 Jul 15;107(2):314-323
pubmed: 25028873
Glycobiology. 2012 Jun;22(6):788-805
pubmed: 22345628
Nat Commun. 2014 Jul 31;5:4428
pubmed: 25079702
J Pathol. 2005 Aug;206(4):451-7
pubmed: 15906273
Virus Res. 1997 Sep;51(1):19-34
pubmed: 9381792
Cell Rep. 2022 Oct 11;41(2):111469
pubmed: 36223739
J Infect Dis. 2006 Jun 15;193(12):1685-92
pubmed: 16703512
J Immunol. 2006 Nov 1;177(9):6192-8
pubmed: 17056548
Nat Cell Biol. 2006 Feb;8(2):156-62
pubmed: 16429129
J Cell Biol. 2009 Jun 1;185(5):769-77
pubmed: 19468066
mBio. 2018 Feb 27;9(1):
pubmed: 29487235
Small. 2022 Feb;18(6):e2105640
pubmed: 34866333
Mol Biol Cell. 2001 Jan;12(1):85-100
pubmed: 11160825
J Clin Invest. 2012 May;122(5):1791-802
pubmed: 22505457
ACS Appl Bio Mater. 2022 Feb 21;5(2):552-561
pubmed: 34995457
J Cell Biol. 2001 Mar 5;152(5):877-94
pubmed: 11238446
Med Hypotheses. 2013 Sep;81(3):489-95
pubmed: 23856243
Nature. 1987 Aug 13-19;328(6131):649-52
pubmed: 3039376
Biochem J. 2010 Mar 15;427(1):79-90
pubmed: 20088823
Mol Cell Biol. 2004 Oct;24(20):9198-206
pubmed: 15456890
Proc Natl Acad Sci U S A. 2022 Feb 22;119(8):
pubmed: 35193960
Biochem Biophys Res Commun. 1991 Mar 29;175(3):955-62
pubmed: 1850997
Oncogene. 2019 May;38(21):4075-4094
pubmed: 30696956
mBio. 2021 Oct 26;12(5):e0254221
pubmed: 34634931
Exp Cell Res. 2007 Jun 10;313(10):2050-62
pubmed: 17512929
Anticancer Res. 2010 Dec;30(12):5239-43
pubmed: 21187520
Sci Rep. 2016 Dec 02;6:38372
pubmed: 27910934
Curr Biol. 2021 May 24;31(10):R522-R529
pubmed: 34033784
Mol Biosyst. 2015 Jan;11(1):159-69
pubmed: 25319351
Mol Biol Cell. 2003 Apr;14(4):1468-78
pubmed: 12686602
J Cell Sci. 2004 Feb 29;117(Pt 6):919-32
pubmed: 14762106
Egypt J Immunol. 2023 Jan;30(1):105-115
pubmed: 36592386
Nucleic Acids Res. 2022 Feb 22;50(3):1370-1381
pubmed: 35100428
Mol Biol Cell. 2008 Oct;19(10):4130-40
pubmed: 18653473
Nat Commun. 2015 Mar 12;6:6574
pubmed: 25762200
Cell. 1990 Sep 21;62(6):1063-71
pubmed: 2169348
Int J Mol Sci. 2020 Jun 30;21(13):
pubmed: 32630064
Microbes Infect. 2000 Aug;2(10):1237-44
pubmed: 11008113
Curr Top Microbiol Immunol. 2020;429:1-18
pubmed: 32060644
Front Pharmacol. 2021 Jul 08;12:627394
pubmed: 34305581
Nat Commun. 2018 Sep 6;9(1):3613
pubmed: 30190500
Nat Rev Immunol. 2015 Sep 15;15(9):559-73
pubmed: 26292640
Nat Cell Biol. 2002 Sep;4(9):681-90
pubmed: 12198493
J Leukoc Biol. 2006 Mar;79(3):489-98
pubmed: 16365157
J Virol. 2014 May;88(10):5816-33
pubmed: 24623428
Proc Natl Acad Sci U S A. 2022 Feb 8;119(6):
pubmed: 35078919
Virol J. 2007 Jan 15;4:7
pubmed: 17224050
J Biol Chem. 1989 Oct 25;264(30):18119-27
pubmed: 2808368
PLoS One. 2012;7(4):e35862
pubmed: 22536447
Cell. 2009 Nov 25;139(5):871-90
pubmed: 19945376
Mol Biol Cell. 2004 Dec;15(12):5369-82
pubmed: 15456899
Front Cell Dev Biol. 2022 Jul 18;10:891281
pubmed: 35923851
Cell Host Microbe. 2008 Aug 14;4(2):159-69
pubmed: 18692775
Glycobiology. 2010 Jul;20(7):843-64
pubmed: 20332081
Front Cell Dev Biol. 2019 Jun 17;7:106
pubmed: 31263698
FASEB J. 2018 May;32(5):2841-2854
pubmed: 29401610
J Proteome Res. 2010 May 7;9(5):2764-74
pubmed: 20329800
Cell Microbiol. 2011 Jan;13(1):47-61
pubmed: 20716207
J Cell Biol. 2005 Nov 7;171(3):431-6
pubmed: 16260496
Mol Immunol. 2018 Dec;104:37-46
pubmed: 30399492
Chem Biol. 2007 Jun;14(6):623-34
pubmed: 17584610
J Virol. 2020 Jan 6;94(2):
pubmed: 31619557
Cardiovasc Res. 2013 Aug 1;99(3):494-504
pubmed: 23674515
Arthritis Rheum. 2000 Aug;43(8):1831-5
pubmed: 10943873
J Virol. 2013 Jun;87(12):6794-803
pubmed: 23576498
Sci Rep. 2022 Apr 29;12(1):7063
pubmed: 35487944
Nat Commun. 2022 May 23;13(1):2842
pubmed: 35606362
Elife. 2018 Mar 07;7:
pubmed: 29513221
PLoS One. 2011 Apr 22;6(4):e19202
pubmed: 21544245
Am J Physiol Cell Physiol. 2010 Feb;298(2):C221-36
pubmed: 19776392
Nature. 2001 Sep 6;413(6851):36-7
pubmed: 11544516
J Biol Chem. 2003 Mar 7;278(10):8526-30
pubmed: 12458200
Eur J Med Chem. 2021 Mar 15;214:113188
pubmed: 33550185
J Biol Chem. 1999 Apr 2;274(14):9881-90
pubmed: 10092680
PLoS Pathog. 2022 Aug 3;18(8):e1010765
pubmed: 35921364
Cell. 1994 Nov 18;79(4):679-94
pubmed: 7954832
Biochim Biophys Acta Mol Cell Res. 2020 Sep;1867(9):118739
pubmed: 32389644
J Immunol. 2004 Aug 15;173(4):2392-401
pubmed: 15294952
Sci Rep. 2018 Nov 19;8(1):16973
pubmed: 30451917
J Cell Biol. 2008 Jun 16;181(6):903-11
pubmed: 18541706
Hum Antibodies. 2018 Feb 5;26(2):95-101
pubmed: 29036806
Sci Rep. 2016 Feb 15;6:21526
pubmed: 26876331
Semin Immunol. 2007 Feb;19(1):24-32
pubmed: 17275323
Proc Natl Acad Sci U S A. 2016 Jul 26;113(30):E4320-7
pubmed: 27466403
iScience. 2022 Nov 18;25(11):105463
pubmed: 36338433

Auteurs

Jeffrey Arrindell (J)

Aix Marseille Univ, Institut de Recherche pour le Développement (IRD), Assistance Publique-Hôpitaux de Marseille (AP-HM), Microbes Evolution Phylogeny and Infections (MEPHI), Marseille, France.
Institut Hospitalo-Universitaire (IHU)-Méditerranée Infection, Marseille, France.

Benoit Desnues (B)

Aix Marseille Univ, Institut de Recherche pour le Développement (IRD), Assistance Publique-Hôpitaux de Marseille (AP-HM), Microbes Evolution Phylogeny and Infections (MEPHI), Marseille, France.
Institut Hospitalo-Universitaire (IHU)-Méditerranée Infection, Marseille, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH